Nail Changes: What Could Be Causing Them and When to See a Doctor

Why Nails Change: The Biology Behind the Signal

The nail plate grows from the matrix at roughly 3 mm per month for fingernails and 1 mm per month for toenails, meaning a full fingernail replacement takes about 6 months 1. Any systemic illness, nutritional deficiency, medication, or local injury that disrupts matrix keratinocyte activity leaves a visible mark in the plate. That mark migrates distally as the nail grows, offering clinicians an approximate timeline.

A 2003 review in the New England Journal of Medicine noted that nail examination can provide diagnostic clues in conditions ranging from endocarditis (splinter hemorrhages) to chronic renal failure (half-and-half nails) 2. The color, texture, shape, and attachment pattern of the nail each point toward different organ systems. Pitting, for example, reflects punctate abnormalities in the proximal matrix and is most strongly associated with psoriasis. Onycholysis (separation of the plate from the bed) can result from thyroid disease, fungal infection, or photo-onycholysis triggered by tetracyclines 3.

Because nails grow slowly, changes often appear weeks or months after the triggering event. That delay is diagnostically useful but can also be confusing for patients who see changes with no obvious recent cause.

Fungal Nail Infections: The Most Common Culprit

Onychomycosis accounts for approximately 50% of all nail disorders evaluated in dermatology practice, with a global prevalence estimated between 5.5% and 13.8% across population studies 4. Dermatophytes, particularly Trichophyton rubrum, are responsible for the vast majority of cases. The typical presentation includes distal-lateral subungual thickening, yellow-white discoloration, and subungual debris.

Diagnosis matters. A 2014 Cochrane review emphasized that clinical appearance alone misidentifies onychomycosis in up to 50% of suspected cases, making laboratory confirmation (KOH prep, fungal culture, or PAS staining of nail clippings) the standard before prescribing systemic antifungals 5. Terbinafine 250 mg daily for 12 weeks remains the first-line oral treatment for dermatophyte toenail onychomycosis, achieving mycologic cure in approximately 70% of patients 6. Topical efinaconazole 10% and tavaborole 5% are FDA-approved alternatives for patients who cannot tolerate systemic therapy, though complete cure rates are lower (15-18% vs. 38-55% for terbinafine) 7.

Risk factors include older age, diabetes, peripheral vascular disease, immunosuppression, and shared bathing facilities. Patients with diabetes and onychomycosis warrant treatment not only for cosmesis but because dystrophic nails increase the risk of secondary bacterial cellulitis 8.

Psoriatic Nail Disease: More Than Skin Deep

Nail involvement occurs in roughly 50% of patients with cutaneous psoriasis and up to 80% of those with psoriatic arthritis, according to data from the Psoriatic Arthritis National Database 9. The Endocrine Society and American Academy of Dermatology both recognize that nail psoriasis is an independent predictor of future joint disease 10.

Classic findings include pitting (small, ice-pick depressions), oil-drop discoloration (translucent yellow-red patches in the nail bed), onycholysis, subungual hyperkeratosis, and crumbling of the plate. The Nail Psoriasis Severity Index (NAPSI) provides a standardized scoring system that clinicians use to track response to therapy 11.

Treatment is challenging. Topical corticosteroids and calcipotriol under occlusion help mild disease. For moderate-to-severe nail psoriasis, biologic therapies have changed outcomes substantially. In the TRANSFIGURE trial, secukinumab 300 mg produced a 63.3% improvement in NAPSI at week 32 compared to 10.8% with placebo 12. Adalimumab, ixekizumab, and guselkumab have also demonstrated significant nail-specific efficacy in randomized trials.

Nutritional Deficiencies and Metabolic Causes

Iron deficiency is the classic metabolic cause of nail changes. Koilonychia (concave, spoon-shaped nails) appears when tissue iron stores are severely depleted, though it can also occur with hemochromatosis or occupational solvent exposure 13. A ferritin level below 10-15 ng/mL strongly suggests iron-deficiency anemia; the nail changes typically resolve within 6 to 12 months of adequate iron supplementation.

Zinc deficiency produces diffuse thinning, Beau lines, and occasionally white transverse bands (Muehrcke lines look-alikes). Patients on long-term proton pump inhibitors or those who have undergone bariatric surgery are at heightened risk 14.

Biotin (vitamin B7) deficiency causes brittle nails, though true deficiency is rare outside of raw-egg-heavy diets, prolonged antibiotic use, or genetic biotinidase deficiency. A systematic review in the Journal of the American Academy of Dermatology found that biotin supplementation (2.5 mg/day) improved nail firmness in patients with documented brittle nails, but the evidence quality was low and most studies were uncontrolled 15.

Thyroid disease deserves special attention. Hypothyroidism slows nail growth and produces dry, brittle nails with prominent longitudinal ridging. Hyperthyroidism accelerates growth but can cause Plummer nails (onycholysis starting at the fourth and fifth digits). Correcting the thyroid abnormality is the primary treatment; nail changes typically improve over 6 to 9 months after achieving euthyroid status 16.

Melanonychia and the Nail Melanoma Question

A longitudinal brown or black streak in a single nail (longitudinal melanonychia) triggers appropriate anxiety. The differential includes benign melanocyte activation, subungual lentigo, ethnic-type melanonychia (present in up to 77% of Black adults over age 50), and subungual melanoma 17.

The ABCDEF mnemonic, proposed by Robert Baran, aids clinical triage: Age (peak 50-70), Band (brown-black, breadth >3 mm, blurred borders), Change (rapid evolution), Digit (thumb, index finger, great toe most common), Extension (Hutchinson sign, pigment extending onto proximal or lateral nail fold), and Family history 18. Any streak meeting two or more of these criteria warrants biopsy.

HealthRX Melanonychia Triage Framework

| Feature | Lower Risk | Higher Risk (Refer for Biopsy) | |---|---|---| | Number of digits | Multiple digits | Single digit | | Band width | <3 mm, stable | >3 mm or widening | | Color | Light brown, homogeneous | Dark brown/black, heterogeneous | | Borders | Sharp, parallel | Blurred, irregular | | Hutchinson sign | Absent | Present (pigment on nail fold skin) | | Patient age | <20 (children have high rates of benign melanonychia) | 50-70 years | | History | Stable for years | New onset or rapid change within months |

Subungual melanoma accounts for only 0.7-3.5% of all melanomas in White populations but represents 15-35% of melanomas in Black, Hispanic, and Asian populations, making vigilance in these groups particularly important 19. Dermoscopy of the nail plate (onychoscopy) can improve diagnostic accuracy by revealing irregular line spacing, color, and thickness.

Drug-Induced Nail Changes

Medications cause a wide variety of nail abnormalities. Chemotherapy is the most recognized offender. Taxanes (docetaxel, paclitaxel) produce onycholysis, subungual hemorrhage, and occasionally permanent nail loss in 30-60% of treated patients 20. Cooling the hands during infusion (cryotherapy) reduces the incidence by about 50% in randomized trials.

Other common drug-nail associations include blue-gray discoloration from minocycline, photo-onycholysis from tetracyclines and fluoroquinolones, and transverse leukonychia (Mees lines) from arsenic, thallium, or high-dose methotrexate 21. Retinoids (isotretinoin, acitretin) thin the nail plate and increase fragility. The effect is dose-dependent and reversible after discontinuation.

A practical point: patients rarely connect new nail changes to a medication started 2 to 4 months earlier. A detailed medication history, including supplements and OTC products, is part of every nail-change workup.

Systemic Disease Clues Written in the Nail

Several systemic conditions leave specific nail signatures that clinicians learn to recognize on physical examination.

Clubbing (increased Lovibond angle >180 degrees, loss of the Schamroth window) is associated with lung cancer, interstitial pulmonary fibrosis, cyanotic congenital heart disease, infective endocarditis, inflammatory bowel disease, and hepatic cirrhosis. A prospective study of 885 patients with newly diagnosed lung cancer found clubbing present in 29% at the time of diagnosis 22. The pathophysiology involves platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) released from platelet clumps trapped in the distal digit vasculature.

Terry nails (white nail bed with a narrow 1-2 mm pink distal band) occur in up to 82% of patients with hepatic cirrhosis and are also seen in congestive heart failure, type 2 diabetes, and chronic kidney disease 23.

Half-and-half nails (Lindsay nails) show a proximal white and distal brown pattern and are found in 20-40% of patients on hemodialysis 24.

Beau lines are transverse depressions reflecting temporary matrix arrest. Severe COVID-19 infection produced visible Beau lines approximately 3-4 months after illness onset in numerous case series published during 2020-2021, consistent with the expected growth delay 25. Other triggers include high fever, major surgery, myocardial infarction, and chemotherapy.

Yellow nail syndrome is a rare triad: slow-growing, thickened yellow nails with loss of the lunula, lymphedema (usually bilateral lower extremity), and pleural effusions or chronic sinopulmonary disease. Mean age at diagnosis is 60 years. Treatment focuses on the underlying lymphatic dysfunction; vitamin E 800 IU daily and fluconazole have shown benefit in case series, though no randomized trials exist 26.

The Diagnostic Workup: What to Expect

Evaluation starts with a thorough history covering the timeline of changes, affected digits, associated symptoms (pain, pruritus, discharge), medical history, medications, occupational exposures, and family history of skin or nail disease. Physical examination should include all 20 nails, the surrounding skin, and the hair and scalp (psoriasis and lichen planus affect multiple keratinized structures).

The American Academy of Dermatology recommends the following studies when the diagnosis is unclear after clinical assessment 27:

• KOH preparation and fungal culture for any nail with thickening, discoloration, or subungual debris
• Nail plate biopsy or nail bed biopsy for melanonychia meeting the ABCDEF criteria, persistent single-nail dystrophy, or suspected lichen planus
• Dermoscopy (onychoscopy) as a noninvasive first step for pigmented lesions
• Complete blood count, ferritin, zinc, thyroid function tests, and comprehensive metabolic panel when multiple nails are affected and a systemic cause is suspected
• Chest radiograph if clubbing is present and no known pulmonary or cardiac diagnosis exists

According to the British Journal of Dermatology, dermatoscopy improves diagnostic accuracy for nail pigmentation from 54% (naked eye) to 83% (dermoscopy-assisted) in a study of 148 longitudinal melanonychia cases 28.

Treatment Approaches by Cause

Treatment depends entirely on the underlying diagnosis.

For onychomycosis, oral terbinafine remains first-line. Itraconazole pulse therapy (200 mg twice daily for one week per month, repeated for 3-4 months) is an alternative, particularly for Candida species. Laser therapy is FDA-cleared for "temporary increase in clear nail" but lacks evidence for mycologic cure and is not recommended as monotherapy by the 2024 AAD guidelines 29.

For psoriatic nail disease, intralesional triamcinolone (2.5-5 mg/mL injected into the proximal nail fold) works for isolated nails. Biologic therapy is preferred for patients with concurrent skin or joint involvement. Ixekizumab produced complete resolution of nail psoriasis (NAPSI = 0) in 37% of patients by week 52 in the IXORA-R trial 30.

For nutritional deficiencies, replace the missing nutrient. Oral ferrous sulfate 325 mg (65 mg elemental iron) two to three times daily for iron-deficiency koilonychia. Zinc sulfate 220 mg daily for zinc deficiency. Expect nail normalization in 6 to 12 months given the slow growth rate.

For drug-induced changes, the primary approach is drug modification when clinically feasible. Cryotherapy mittens during taxane infusions are the most evidence-supported preventive intervention 31.

For melanonychia, excisional biopsy of the matrix is both diagnostic and therapeutic for subungual melanoma in situ. Breslow thickness determines staging and surgical margins, as with cutaneous melanoma 32.

When to Seek Medical Evaluation

Not every nail change requires a doctor visit. Minor trauma, a single white spot (punctate leukonychia), and mild ridging in older adults are benign and self-resolving. The following warrant prompt evaluation:

• A new dark streak in a single nail, especially if it is widening or has blurred borders
• Painful, red, swollen nail folds with purulent discharge (acute paronychia)
• Nail changes accompanied by joint pain or stiffness (psoriatic arthritis screening)
• Clubbing of the fingertips
• Splinter hemorrhages with fever (endocarditis workup)
• Progressive dystrophy of all nails without clear cause

The Endocrine Society guidelines recommend checking thyroid function in patients presenting with diffuse nail brittleness, hair thinning, and fatigue, as this triad is a common presentation of subclinical hypothyroidism 33.

Patients with diabetes should have their nails examined at every foot check. The American Diabetes Association 2024 Standards of Care include nail assessment as part of the comprehensive lower-extremity examination, given the elevated risk of onychomycosis, paronychia, and ingrown nails leading to secondary infection 34.